MedTrace Logo

Prospective, Multi-center, Single-arm Study to Assess the Safety of Retrieval of the Recovery G2 Filter.

NCT00556426 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2012-06-01

Study results available
· View outcomes & findings →

Summary

This study was designed to assess the safety of retrieval of the Bard Recovery® G2® Filter System. The G2 filter is an FDA-cleared device for inferior vena caval interruption in patients with pulmonary thromboembolism.

Conditions

Interventions

DEVICE

Bard Recovery G2 Filter System

Retrieval of previously placed RECOVERY G2 IVC filter

Sponsors & Collaborators

  • C. R. Bard

    lead INDUSTRY

Principal Investigators

  • John A Kaufman, MD · OHSU, Portland, Oregon

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31
Primary Completion
2007-04-30
Completion
2007-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00556426 on ClinicalTrials.gov